ASSESSMENT RESULTS OF LASER TREATMENT TREATMENT WITH Q-SWITCHED ND:YAG COMBINATION WITH MELATONIN CREAM, TRI-WHITE SERUM AT CAN THO UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL AND FOB INTERNATIONAL COSMETIC DERMATOLOGY INSTITUTE IN 2022-2023

Trúc Linh Lưu 1, Văn Bá Huỳnh 1, Minh Vinh Ngô 2, Hồng Hà Nguyễn 1
1 Can Tho University of Medicine - Pharmacy
2 Pham Ngoc Thach University of Medicine

Main Article Content

Abstract

Background: Melasma is a common skin disease, often appearing in areas exposed to light. Presented by gray-brown macules on face, symmetrically distributed, may be continuous or scattered, not life-threatening. Objects: Evaluating the results of melasma treatment with Q-switched Nd:YAG Laser combined with Melatonin cream, Tri-white serum applied at Can Tho university of medicine and pharmacy hospital and FOB international cosmetic dermatology institute in 2022-2023. Materials and methods: Cross-sectional descriptive study on 41 patients who came for examination and were diagnosed with melasma at Can Tho university of medicine and pharmacy hospital and FOB international cosmetic dermatology institute from August 2022 to August 2023. Results: No new lesions appeared, accounting for 82.9% (time T1), 87.8% (time T2), 91.7% (time T3), 89.5% (time T4). Unwanted effects were the highest: skin redness was 53.7% at T1 and 58.3% at T3, stinging was highest at 63.4% at T2 and 57.9% at T4. Results of Q-switched ND:YAG laser treatment for melasma combined with Melatonin cream and Tri-white serum were successful in 95.1% (78% cured, 17.1% reduced), unsuccessful 4 ,9%. Patients' feelings after treatment showed that 56.1% were very satisfied, 26.8% were satisfied, and 17.1% were normal. Treatment results according to MASI melasma classification have statistical significance p<0.001. Conclusions: The results of melasma treatment with Q-switched ND:YAG laser combined with Melatonin cream and Tri-white serum were successful in 95.1% (78% cure, 17.1% disease reduction). Patients' feelings after treatment showed that 56.1% were very satisfied, 26.8% were satisfied, and 17.1% were normal.

Article Details

References

1. Lê Minh Hoài (2020), Nghiên cứu đặc điểm lâm sàng và đánh giá điều trị rám má bằng laser Q-Switched Nd: YAG kết hợp bôi Tri-white serum tại Bệnh viện Trường Đại học Y dược Cần Thơ, Luận văn chuyên khoa II, Đại học Y dược Cần Thơ.
2. Lê Thái Vân Thanh (2015), Nghiên cứu rám má trên phụ nữ có thai và một số biện pháp can thiệp, Luận án tiến sĩ Y học, Đại học Y Hà Nội.
3. Jang H. W., Chun S. H., Park H. C., Ryu H. J., (2016), Comparative study of dual-pulsed 1,064 nm Qswitched Nd:YAG laser and single-pulsed 1,064 nm Q-switched Nd:YAG laser by using zebrafish model and prospective split-face analysis of facial melasma, Journal of Cosmetic and Laser Therapy. ISSN: 1476-4172 (Print) 1476-4180 (Online).
4. Guo X., Cai X., Jin Y., et al., (2019), “Q-PTP is an optimized technology of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the laser therapy of melasma: A prospective split-face study”, Oncology Letters, pp. 4136-4143.
5. Choi J. E., Lee D. W., Seo S. H.,, et al., (2018), “Low‑fluence Q‑switched Nd:YAG laser for the treatment of melasma in Asian patients”, J Cosmet Dermatol, pp. 1-6.
6. Cheng J., Vashi N. A. (2017), “Chemical Peels in Ethnic Skin”, pp. 437- 448.
7. Gokalp H., Akkaya A. D., Yasemin Oram Y., (2016), “Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective?”, Journal of Cosmetic Dermatology. 2016, pp. 1-7.
8. Hofbauer Parra C.A., Careta M.F., Valente N.Y.S., et al., (2016), “Clinical and Histopathologic Assessment of Facial Melasma After Low-Fluence QS Nd:YAG Laser”, Dermatol Surg. 2016, pp. 1-6.
9. Kaminaka C., Furukawa F., Yamamoto Y., (2017), “The Clinical and Histological Effect of a Low-Fluence Q-Switched 1,064-nm Neodymium:Yttrium-AluminumGarnet Laser for the Treatment of Melasma and Solar Lentigo in Asians: Prospective, Randomized, and Split-Face Comparative Study”, Dermatol Surg, pp. 1-14.